References
- Bettin P, Matteo FD. Glaucoma: present challenges and future trends. Ophthalmic Res. 2013;50:197–208. doi:https://doi.org/10.1159/000348736.
- Mantravadi AV, Vadhar N. Glaucoma. Prim Care. 2015;42:437–49. doi:https://doi.org/10.1016/j.pop.2015.05.008.
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. Jama. 2014;311:1901. doi:https://doi.org/10.1001/jama.2014.3192.
- Mishra S. Electroceuticals in medicine – the brave new future. Indian Heart J. 2017;69:685–86. doi:https://doi.org/10.1016/j.ihj.2017.10.001.
- Bak MJ, McIntosh JS, Scmidt EM. Long-term implants of parylene-c coated microelectrodes. Med Biol Eng Comput. 1988;26:96–101. doi:https://doi.org/10.1007/BF02441836.
- Pederson DJ, Quinkert CJ, Arafat MA, Somann JP, Williams JD, Bercich RA, Wang Z, Albors GO, Jeffreys JGR, Irazoqui PP. The Bionode. ACM Trans Embedded Comput Syst. 2019;18:1–20.
- Williams NR, Okun MS. Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest. 2013;123:4546–56. doi:https://doi.org/10.1172/JCI68341.
- Ward MP, Qing KY, Otto KJ, Worth RM, Simon JWM, Irazoqui PP, Flexible A. Platform for biofeedback-driven control and personalization of electrical nerve stimulation therapy. IEEE Trans Neural Syst Rehabil Eng. 2014;1:1. doi:https://doi.org/10.1109/TNSRE.2014.2351271.
- Vos CD, Melching L, Schoonhoven JV, Ardesch J, Weerd AD, Lambalgen HV, Putten MV. Predicting success of vagus nerve stimulation (VNS) from interictal EEG. Seizure. 2011;20(7):541–45. doi:https://doi.org/10.1016/j.seizure.2011.04.002.
- US20040210274A1 - patient directed therapy management. Google patents; [accessed 2019 Dec 2]. https://patents.google.com/patent/US20040210274A1/en.
- Cheema A, Chang RT, Shrivastava A, Singh K. Update on the medical treatment of primary open-angle glaucoma. Asia Pac J Ophthalmol. 2016;5:51–58. doi:https://doi.org/10.1097/APO.0000000000000181.
- Marquis RE, Whitson JT. Management of glaucoma: focus on pharmacological therapy. Drugs Aging. 2005;22:1–21. doi:https://doi.org/10.2165/00002512-200522010-00001.
- Hylton C, Robin AL. Update on prostaglandin analogs. Curr Opin Ophthalmol. 2003;14:65–69. doi:https://doi.org/10.1097/00055735-200304000-00001.
- Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmol. 1996;103:138–47. doi:https://doi.org/10.1016/S0161-6420(96)30749-5.
- Netland PA, Landry T, Sullivan E, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472–84. doi:https://doi.org/10.1016/S0002-9394(01)01177-1.
- Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik C, Shams N. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. Am J Ophthalmol. 2002;133:1–10. doi:https://doi.org/10.1016/S0002-9394(01)01337-X.
- Ramona B, Monica P, Paul-Eduard S, Speranta S, Calin-Petru T. Intraoperative and postoperative complications in trabeculectomy, clinical study. Rom J Ophthalmol. 2015;59:243–47.
- Chen DZ, Sng CCA. Safety and efficacy of microinvasive glaucoma surgery. J Ophthalmol. 2017;2017:1–13.
- Suzuki R, Dickens CJ, Iwach AG, Hoskins HD, Hetherington J, Juster RP, Wong PC, Klufas MT, Leong CJ, Nguyen N. Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmol. 2002;109:1921–24. doi:https://doi.org/10.1016/S0161-6420(02)01186-7.